Literature DB >> 16602110

Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft.

Darrel Brodke1, Hugo A Pedrozo, Terri A Kapur, Mohamed Attawia, Karl H Kraus, Chantal E Holy, Sudha Kadiyala, Scott P Bruder.   

Abstract

Using a canine critical-size segmental defect model, a two-phased study was undertaken to evaluate the healing efficacy of demineralized bone and cancellous chips (DBM-CC) enriched with osteoprogenitor cells using a Selective Cell Retention (SCR) technology. The goals of this study were: 1) to determine the bone-healing efficacy of SCR-enriched grafts versus autograft, and 2) to assess the value of clotting SCR-enriched grafts with platelet-rich plasma (PRP). Thirty dogs were included in Phase I: 18 dogs were treated with an SCR-enriched DBM-CC graft clotted with autologous bone marrow, and were compared to 12 autograft controls. In Phase II, 24 animals were divided into 4 groups of 6 animals, each treated with a different bone graft material: 1) iliac crest autograft, 2) DBM-CC alone, 3) DBM-CC saturated with marrow, and 4) SCR-enriched DBM-CC clotted with PRP. All grafts were placed unilaterally in a 21-mm long osteoperiosteal femoral, instrumented, critical-size defect. Radiographs were obtained for all animals postoperatively and every 4-16 weeks; animals were then sacrificed. All femurs were prepared for histology. Femurs in the Phase II study were also analyzed by micro-CT. At 16 weeks, healing--defined by bridging bone across the defects--was observed in 50% of the DBM-CC alone group and 67% of the DBM-CC saturated with marrow group; 100% of the autograft and SCR-enriched DBM-CC groups were healed. Histologically, grafts clotted with PRP showed more mature bone than those implanted with autologous bone, which in turn were similar to those implanted with bone marrow clotted SCR-enriched grafts. These results demonstrated that: 1) SCR-enriched DBM-CC was equivalent to autograft to repair critical-size defects, and 2) while not statistically significant, PRP may have accelerated bone maturation when used to clot osteoprogenitor-enriched DBM-CC grafts--as compared to cell-enriched, DBM-CC grafts without PRP--in large animal models. Copyright 2006 Orthopaedic Research Society.

Entities:  

Mesh:

Year:  2006        PMID: 16602110     DOI: 10.1002/jor.20094

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  12 in total

1.  Formation of osteogenic colonies on well-defined adhesion peptides by freshly isolated human marrow cells.

Authors:  Ada Au; Cynthia A Boehm; Anne M Mayes; George F Muschler; Linda G Griffith
Journal:  Biomaterials       Date:  2007-01-11       Impact factor: 12.479

2.  Matrix-specific anchors: a new concept for targeted delivery and retention of therapeutic cells.

Authors:  Andrzej Steplewski; Jolanta Fertala; Pedro Beredjiklian; Mark L Wang; Andrzej Fertala
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

Review 3.  Intraoperative stem cell therapy.

Authors:  Mónica Beato Coelho; Joaquim M S Cabral; Jeffrey M Karp
Journal:  Annu Rev Biomed Eng       Date:  2012       Impact factor: 9.590

4.  The influence of tethered epidermal growth factor on connective tissue progenitor colony formation.

Authors:  Nicholas A Marcantonio; Cynthia A Boehm; Richard J Rozic; Ada Au; Alan Wells; George F Muschler; Linda G Griffith
Journal:  Biomaterials       Date:  2009-06-21       Impact factor: 12.479

Review 5.  Stem Cell Therapies in Orthopaedic Trauma.

Authors:  Ralph S Marcucio; Aaron Nauth; Peter V Giannoudis; Chelsea Bahney; Nicolas S Piuzzi; George Muschler; Theodore Miclau
Journal:  J Orthop Trauma       Date:  2015-12       Impact factor: 2.512

6.  Tethering of Epidermal Growth Factor (EGF) to Beta Tricalcium Phosphate (βTCP) via Fusion to a High Affinity, Multimeric βTCP-Binding Peptide: Effects on Human Multipotent Stromal Cells/Connective Tissue Progenitors.

Authors:  Luis M Alvarez; Jaime J Rivera; Linda Stockdale; Sunil Saini; Richard T Lee; Linda G Griffith
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

7.  Osteogenic ability of bone marrow stem cells intraoperatively enriched by a novel matrix.

Authors:  Qing Ye; Kaining Chen; Wu Huang; Yunsong He; Mingshan Nong; Chunxiang Li; Tiansen Liang
Journal:  Exp Ther Med       Date:  2014-11-12       Impact factor: 2.447

8.  Selective Retention of Bone Marrow Stromal Cells with Gelatin Sponge for Repair of Intervertebral Disc Defects after Microendoscopic Discectomy: A Prospective Controlled Study and 2-Year Follow-Up.

Authors:  Baoshan Xu; Hao Zhang; Lilong Du; Qiuming Yuan; Kaihui Zhang; Haiwei Xu; Xinlong Ma; Yue Liu; Hongfeng Jiang; Ning Li
Journal:  Biomed Res Int       Date:  2021-07-13       Impact factor: 3.411

9.  Repair of orbital bone defects in canines using grafts of enriched autologous bone marrow stromal cells.

Authors:  Yefei Wang; Xiaoping Bi; Huifang Zhou; Yuan Deng; Jing Sun; Caiwen Xiao; Ping Gu; Xianqun Fan
Journal:  J Transl Med       Date:  2014-05-11       Impact factor: 5.531

10.  Assessment of Methods for Rapid Intraoperative Concentration and Selection of Marrow-Derived Connective Tissue Progenitors for Bone Regeneration Using the Canine Femoral Multidefect Model.

Authors:  Viviane Luangphakdy; Cynthia Boehm; Hui Pan; James Herrick; Phil Zaveri; George F Muschler
Journal:  Tissue Eng Part A       Date:  2016-01       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.